Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.

Allen JE, Ferrini R, Dicker DT, Batzer G, Chen E, Oltean DI, Lin B, Renshaw MW, Kretz-Rommel A, El-Deiry WS.

Mol Cancer Ther. 2012 Oct;11(10):2087-95. doi: 10.1158/1535-7163.MCT-12-0366. Epub 2012 Jul 16.

2.

A step-wise approach significantly enhances protein yield of a rationally-designed agonist antibody fragment in E. coli.

Lin B, Renshaw MW, Autote K, Smith LM, Calveley P, Bowdish KS, Frederickson S.

Protein Expr Purif. 2008 May;59(1):55-63. doi: 10.1016/j.pep.2008.01.002. Epub 2008 Jan 17.

PMID:
18314349
3.

A rationally designed agonist antibody fragment that functionally mimics thrombopoietin.

Frederickson S, Renshaw MW, Lin B, Smith LM, Calveley P, Springhorn JP, Johnson K, Wang Y, Su X, Shen Y, Bowdish KS.

Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14307-12. Epub 2006 Sep 14.

4.

Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.

Ramos JW, Hughes PE, Renshaw MW, Schwartz MA, Formstecher E, Chneiweiss H, Ginsberg MH.

Mol Biol Cell. 2000 Sep;11(9):2863-72.

5.
6.
7.

Growth factor activation of MAP kinase requires cell adhesion.

Renshaw MW, Ren XD, Schwartz MA.

EMBO J. 1997 Sep 15;16(18):5592-9.

8.

Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway.

Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA, Ginsberg MH.

Cell. 1997 Feb 21;88(4):521-30.

9.

Involvement of the small GTPase rho in integrin-mediated activation of mitogen-activated protein kinase.

Renshaw MW, Toksoz D, Schwartz MA.

J Biol Chem. 1996 Sep 6;271(36):21691-4.

10.

The regulation of growth and intracellular signaling by integrins.

Meredith JE Jr, Winitz S, Lewis JM, Hess S, Ren XD, Renshaw MW, Schwartz MA.

Endocr Rev. 1996 Jun;17(3):207-20. Review. No abstract available.

PMID:
8771356
11.

Rac is required for v-Abl tyrosine kinase to activate mitogenesis.

Renshaw MW, Lea-Chou E, Wang JY.

Curr Biol. 1996 Jan 1;6(1):76-83.

12.
13.

Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.

Renshaw MW, Kipreos ET, Albrecht MR, Wang JY.

EMBO J. 1992 Nov;11(11):3941-51.

14.

Differential expression of type-specific c-abl mRNAs in mouse tissues and cell lines.

Renshaw MW, Capozza MA, Wang JY.

Mol Cell Biol. 1988 Oct;8(10):4547-51.

Supplemental Content

Loading ...
Support Center